Showing results (51-60 of 1,393) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|February 9, 2022
Precision Oncology in Solid Tumors: A Longitudinal Tertiary Care Center ExperienceMeena Sadaps, Pauline Funchain, Haider Mahdi, et al.
JCO Precision Oncology|February 9, 2022
Validating Comprehensive Next-Generation Sequencing Results for Precision Oncology: The NCT/DKTK Molecularly Aided Stratification for Tumor Eradication Research ExperienceAmelie Lier, Roland Penzel, Christoph Heining, et al.
JCO Precision Oncology|February 17, 2022
Circulating Tumor DNA Analysis and Functional Imaging Provide Complementary Approaches for Comprehensive Disease Monitoring in Metastatic MelanomaStephen Q Wong, Jeanette M Raleigh, Jason Callahan, et al.
JCO Precision Oncology|February 17, 2022
Programmed Cell Death 1 (PD-1) Ligand (PD-L1) Expression in Solid Tumors As a Predictive Biomarker of Benefit From PD-1/PD-L1 Axis Inhibitors: A Systematic Review and Meta-AnalysisMonica Khunger, Adrian V Hernandez, Vinay Pasupuleti, et al.
JCO Precision Oncology|February 17, 2022
Molecular and Clinical Characterization of a Claudin-Low Subtype of Gastric CancerTomohiro F Nishijima, Jordan Kardos, Shengjie Chai, et al.
JCO Precision Oncology|February 17, 2022
Breast and Ovarian Cancer Penetrance Estimates Derived From Germline Multiple-Gene Sequencing Results in WomenAllison W Kurian, Elisha Hughes, Elizabeth A Handorf, et al.
JCO Precision Oncology|February 17, 2022
Programmed Death-Ligand 1 Expression in a Large Cohort of Pediatric Patients With Solid Tumor and Association With Clinicopathologic Features in NeuroblastomaFederica Saletta, Ricardo E Vilain, Aditya Kumar Gupta, et al.
JCO Precision Oncology|February 17, 2022
Graft-Versus-Leukemia Effect of Allogeneic Stem-Cell Transplantation and Minimal Residual Disease in Patients With Acute Myeloid Leukemia in First Complete RemissionJurjen Versluis, Burak Kalin, Wendelien Zeijlemaker, et al.
JCO Precision Oncology|February 17, 2022
High-Content Biopsies Facilitate Molecular Analyses and Do Not Increase Complication Rates in Patients With Advanced Solid TumorsNathan E Frenk, Laura Spring, Alona Muzikansky, et al.
JCO Precision Oncology|February 17, 2022
PTEN Promoter Variants Are Not Associated With Common Cancers: Implications for Multigene Panel TestingMary Helen Black, Shuwei Li, Tina Pesaran, et al.
Pageof 140